Toronto, Ontario – August 3, 2022 – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“Pharmadrug” or the “Company“), is pleased to announce that it has closed the previously announced (see press release dated May 31, 2022) sale of all of the issued and outstanding...
Toronto, Ontario – August 2, 2022 – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...
Results show that oral cepharanthine plus paclitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 28, the final day of dosing compared to paclitaxel alone (p=0.0049) Dose range finding demonstrates that oral...
VANCOUVER, British Columbia, June 08, 2022 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has completed the settlement (the “Debt Settlement”) of US$18.34 million of indebtedness which...
–Real-time Energy and Emission Reduction Technology– TORONTO – Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”) a leader in smart buildings and cities through IoT, Cloud and SaaS technology, has...
Selection of lead candidate from initial short-list of 6 DMT-analogues Lead candidate displays superior potency in two in vitro bioassays on two relevant human cell types In vitro safety and biocompatibility testing using drug-loaded medical device demonstrates...
